QNTM (QNTM) Stock Price & Analysis
QNTM (QNTM) fell 3.95% to USD 3.89 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
QNTM last closed at USD 4.05; the session ranged USD 3.59–4.1 on volume of 320,319 shares. Market capitalization is $24.89M, with a 52-week range of USD 2.07–38.25 (NCM). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 3.89 |
|---|---|
| Change | ▼ 3.95% (down) |
| Previous Close | USD 4.05 |
| Open | USD 4.07 |
| Day Range | USD 3.59 – 4.1 |
| 52-Week Range | USD 2.07 – 38.25 |
| Volume | 320,319 shares |
| Market Cap | $24.89M |
| Exchange | NCM |
Technical Analysis (QNTM)
Nexqual's technical model rates QNTM "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.62 (neutral) |
| vs SMA50 | Below (USD 4.97) |
| MACD | -0.26 (negative) |
Analyst Ratings (QNTM)
Wall Street analysts rate QNTM "None" based on 1 analysts, with a mean price target of USD 12.5 (range USD 12.5–12.5), per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 12.5 |
| High Target | USD 12.5 |
| Low Target | USD 12.5 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (QNTM)
| Revenue Estimate | $0 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -4.17 vs est -0.68 ▼ miss |
| 2025-09-30 | USD -1.77 vs est -3.7 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (QNTM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -2056.51% |
| Current Ratio | 0.63 |
| Total Cash | $4.56M |
| Total Debt | $870,057 |
| Free Cash Flow | $2.16M |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (QNTM)
Nexqual rates QNTM's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $5M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -2057%, ROA -62.4% |
Ownership (QNTM)
| Insider Ownership | +12.36% |
|---|---|
| Institutional Ownership | +9.86% |
| Shares Outstanding | 6.40M |
| Float | 5.93M |
| Short % of Float | +3.82% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (QNTM)
QNTM is led by Zeeshan Saeed (age 55), Co-Founder, CEO & Executive Non-Independent Co-Chairman, per Nexqual as of June 10, 2026 at 00:51 UTC.
| Co-Founder, CEO & Executive Non-Independent Co-Chairman | Zeeshan Saeed (age 55) |
|---|---|
| Co-Founder & Executive Non-Independent Co-Chairman | Anthony John Durkacz (age 49) |
| Chief Financial Officer | Donal Carroll (age 48) |
| Vice President of Clinical & Scientific Affairs | Andrzej Chruscinski |
| Director of Pharmaceutical Development | Ashwini Joshi M.S. |
Major Backers & Investors (QNTM)
Notable institutional backers of QNTM include AdvisorShares Trust-AdvisorShares Psychedelics ETF, AdvisorShares Investments, LLC, Platform Technology Partners, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 4.31% |
| AdvisorShares Investments, LLC | 2.84% |
| Platform Technology Partners | 1.08% |
| Jane Street Group, LLC | 0.83% |
| Citadel | 0.42% |
| Marex Group Plc | 0.35% |
| Virtu Financial LLC | 0.32% |
| Mariner, LLC | 0.26% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SEG | Seaport Entertainment Group Inc | USD 24.08 | ▲ 0.58% |
| AIFF | Firefly Neuroscience, Inc. | USD 1.61 | ▲ 1.9% |
| APM | Aptorum Group Limited | USD 1.12 | ▲ 10.89% |
| JTAI | Jet.AI Inc. | USD 7.81 | ▲ 2.76% |
| DWTX | Dogwood Therapeutics, Inc. | USD 1.45 | ▼ 3.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.